Pregabalin-induced hepatotoxicity

Annals of Pharmacotherapy

Volumn 45, Issue 6, 2011, Pages 32-

  Sendra, Juan Moll ^a   Junyent, Teresa Torrecilla ^a   Pellicer, Maria José Remigia ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Hepatotoxicity; Pregabalin

Indexed keywords

ALANINE AMINOTRANSFERASE; ALLOPURINOL; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; C REACTIVE PROTEIN; CREATININE; DIPYRONE; GAMMA GLUTAMYLTRANSFERASE; HAEMOPHILUS INFLUENZAE VACCINE; LACTATE DEHYDROGENASE; LEVOFLOXACIN; LIVER ENZYME; POLIOMYELITIS VACCINE; PREGABALIN; RAPAMYCIN; TACROLIMUS;

ADULT; ANKLE EDEMA; ARTICLE; BLOOD CELL COUNT; CASE REPORT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENZYME BLOOD LEVEL; FEVER; GOUT; HUMAN; LEUKOCYTE; LIVER TOXICITY; MALE; MANTLE CELL LYMPHOMA; NEUROPATHIC PAIN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SIDE EFFECT; SINGLE DRUG DOSE;

ANALGESICS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-INDUCED LIVER INJURY; GAMMA-AMINOBUTYRIC ACID; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOSIDEROSIS; HUMANS; LIVER FUNCTION TESTS; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; NEURALGIA; TIME FACTORS;

EID: 79958810666     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1Q032     Document Type: Article

References (10)

1. Field MJ, Cox PJ, Stott E, et al. Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin. Proc Natl Acad Sci U S A 2006;103:17537-42. DOI 10.1073/pnas.0409066103
2. Chalasani N, Björnsson E. Risk factors for idiosyncratic drug-induced liver injury. Gastroenterology 2010;138:2246-59. DOI 10.1053/j.gastro. 2010.04.001
3. Ljungman P, Cordonnier C, Einsele H, et al. Vaccination of hematopoietic cell transplant recipients. Bone Marrow Transplant 2009;44:521-6. DOI 10.1038/bmt.2009.263
4. Shneker BF, McAuley JW. Pregabalin: a new neuromodulator with broad therapeutic indications. Ann Pharmacother 2005;39:2029-37. DOI 10.1345/aph.1G078
5. Einarsdottir S, Björnsson E. Pregabalin as a probable cause of acute liver injury. Eur J Gastroenterol Hepatol 2008;20:1049. DOI 10.1097/MEG.0b013e328300c978
6. Lindh J. Hepatic adverse effects of pregabalin (Lyrica). Lakartidningen 2010;107:194.
7. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239- 245. DOI 10.1038/clpt.1981.154
8. Danan G, Benichou C. Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993;46:1323-30. DOI 10.1016/0895-4356(93)90101-6
9. Socié G, Salooja N, Cohen A, et al. Nonmalignant late effects after allogeneic stem cell transplantation. Blood 2003;101:3373-85. DOI 10.1182/blood-2002-07-2231
10. Ben-Menachem E. Pregabalin pharmacology and its relevance to clinical practice. Epilepsia 2004;45:13-18. DOI 10.1111/j.0013-9580.2004.455003.x Pregabalin-Induced Hepatotoxicity theannals.